0

Lexicon Pharmaceuticals Inc (LXRX) – Financial and Strategic SWOT Analysis Review

Publisher Name :
Date: 6-Jun-2017
No. of pages: 45

Lexicon Pharmaceuticals Inc (LXRX) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

– Business description – A detailed description of the company’s operations and business divisions.
– Corporate strategy – Analyst’s summarization of the company’s business strategy.
– SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
– Company history – Progression of key events associated with the company.
– Major products and services – A list of major products, services and brands of the company.
– Key competitors – A list of key competitors to the company.
– Key employees – A list of the key executives of the company.
– Executive biographies – A brief summary of the executives’ employment history.
– Key operational heads – A list of personnel heading key departments/functions.
– Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
– Key manufacturing facilities – A list of key manufacturing facilities of the company.
– Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
– Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Lexicon Pharmaceuticals Inc (Lexicon) is a biopharmaceutical company, which focuses on the discovery, development and commercialization of innovative treatments for human diseases. The company has advanced multiple drug candidates into clinical development and has clinical-stage drug program sotagliflozin (LX4211) for type 1 and type 2 diabetes and its approved product Xermelo (telotristat ethyl) for the treatment of carcinoid syndrome. Lexicon’s clinical and preclinical development programs, LX2761 and LX9211 are focused at treating diabetes and neuropathic pain respectively. Lexicon has its laboratory at Texas. It has business collaborations with several pharmaceutical and biotechnology companies. Lexicon is headquartered at The Woodlands, Texas, the US.

Lexicon Pharmaceuticals Inc Key Recent Developments

May 02,2017: Lexicon Pharmaceuticals Reports First Quarter 2017 Financial Results And Provides A Business Update
Mar 03,2017: Lexicon Pharmaceuticals Provides Clinical Pipeline Update And Reports 2016 Fourth Quarter And Full Year Financial Results
Nov 01,2016: Lexicon Pharmaceuticals Provides Clinical Pipeline Update And Reports 2016 Third Quarter Financial Results
Aug 04,2016: Lexicon Pharmaceuticals Provides Clinical Pipeline Update and Reports 2016 Second Quarter Financial Results
May 10,2016: Praveen Tyle, Ph.d. Joins Lexicon as Executive Vice President of Research and Development

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
– The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
– The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
– Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
– Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
– Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

Table of content
Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Section 1 - About the Company 5
Lexicon Pharmaceuticals Inc - Key Facts 5
Lexicon Pharmaceuticals Inc - Key Employees 6
Lexicon Pharmaceuticals Inc - Key Employee Biographies 7
Lexicon Pharmaceuticals Inc - Major Products and Services 8
Lexicon Pharmaceuticals Inc - History 9
Lexicon Pharmaceuticals Inc - Company Statement 11
Lexicon Pharmaceuticals Inc - Locations And Subsidiaries 12
Head Office 12
Other Locations & Subsidiaries 12
Section 2 - Company Analysis 13
Lexicon Pharmaceuticals Inc - Business Description 13
Lexicon Pharmaceuticals Inc - SWOT Analysis 14
SWOT Analysis - Overview 14
Lexicon Pharmaceuticals Inc - Strengths 14
Lexicon Pharmaceuticals Inc - Weaknesses 15
Lexicon Pharmaceuticals Inc - Opportunities 16
Lexicon Pharmaceuticals Inc - Threats 17
Lexicon Pharmaceuticals Inc - Key Competitors 18
Section 3 - Company Financial Ratios 19
Financial Ratios - Capital Market Ratios 19
Financial Ratios - Annual Ratios 20
Performance Chart 22
Financial Performance 22
Financial Ratios - Interim Ratios 23
Financial Ratios - Ratio Charts 24
Section 4 - Company's Lifesciences Financial Deals and Alliances 25
Lexicon Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 25
Lexicon Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Type, 2011 to YTD 2017 26
Lexicon Pharmaceuticals Inc, Recent Deals Summary 27
Section 5 - Company's Recent Developments 28
May 02, 2017: Lexicon Pharmaceuticals Reports First Quarter 2017 Financial Results And Provides A Business Update 28
Mar 03, 2017: Lexicon Pharmaceuticals Provides Clinical Pipeline Update And Reports 2016 Fourth Quarter And Full Year Financial Results 30
Nov 01, 2016: Lexicon Pharmaceuticals Provides Clinical Pipeline Update And Reports 2016 Third Quarter Financial Results 32
Aug 04, 2016: Lexicon Pharmaceuticals Provides Clinical Pipeline Update and Reports 2016 Second Quarter Financial Results 34
May 10, 2016: Praveen Tyle, Ph.d. Joins Lexicon as Executive Vice President of Research and Development 36
May 03, 2016: Lexicon Pharmaceuticals Provides Clinical Pipeline Update And Reports 2016 First Quarter Financial Results 37
Mar 01, 2016: Lexicon Pharmaceuticals Provides Clinical Pipeline Update and Reports 2015 Fourth Quarter and Full Year Financial Results 39
Section 6 - Appendix 41
Methodology 41
Ratio Definitions 41
About GlobalData 45
Contact Us 45
Disclaimer 45

List of Tables
Lexicon Pharmaceuticals Inc, Key Facts 5
Lexicon Pharmaceuticals Inc, Key Employees 6
Lexicon Pharmaceuticals Inc, Key Employee Biographies 7
Lexicon Pharmaceuticals Inc, Major Products and Services 8
Lexicon Pharmaceuticals Inc, History 9
Lexicon Pharmaceuticals Inc, Subsidiaries 12
Lexicon Pharmaceuticals Inc, Key Competitors 18
Lexicon Pharmaceuticals Inc, Ratios based on current share price 19
Lexicon Pharmaceuticals Inc, Annual Ratios 20
Lexicon Pharmaceuticals Inc, Annual Ratios (Cont...1) 21
Lexicon Pharmaceuticals Inc, Interim Ratios 23
Lexicon Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 25
Lexicon Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Type, 2011 to YTD 2017 26
Lexicon Pharmaceuticals Inc, Recent Deals Summary 27
Currency Codes 41
Capital Market Ratios 41
Equity Ratios 42
Profitability Ratios 42
Cost Ratios 43
Liquidity Ratios 43
Leverage Ratios 44
Efficiency Ratios 44

List of Figures
Lexicon Pharmaceuticals Inc, Performance Chart (2012 - 2016) 22
Lexicon Pharmaceuticals Inc, Ratio Charts 24
Lexicon Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 25
Lexicon Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 26

News

  • Understanding the Need For Travel Vaccination
  • If you are getting ready for a particular trip that can see you away from your house for about a month or so, then it is necessary for you to take the help of travel vaccinations. Not ...
  • The Work Of The Ophthalmology Specialist
  • When we consider ophthalmology as a branch of science, it is actually about the treatment as well as getting to diagnose the different kinds of diseases and the disorder that is to ...
  • The Process Of Dental Implants And The Subsequent Recovery
  • In the United States of America, the fear of going to a dentist happens to rank number one on the list of children as well as adults. Most of the people are actually concerned when ...
  • The medication that can help the rural population
  • It is not always that you get to see world class hospitals in the rural areas, be it America or any other country. Hence, it is important that people actually take the help of tele-medication, ...
  • The Future of Telemedicine & Its Use
  • When talking about telemedicine, you do get to realize that it is the healthcare of the future. Most of the people do not realize the implications, and for more so the time, telemedicine ...

Get Updates

Share This Post

Recent Posts

© 2021 RnR Company Profiles. All rights reserved.